Rat liver nuclear nifurtimox nitroreductase activity

Research Communications in Molecular Pathology and Pharmacology

Volumn 98, Issue 3, 1997, Pages 249-254

  De Toranzo, E G D ^a   Herrera, D M ^a   Castro, J A ^a  

^a Instituto de Investigaciones Cientificas y Tecnicas de Las Fuerzas Armadas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYTOCHROME P450; DNA; LIVER ENZYME; MALONALDEHYDE; NIFURTIMOX; NITROGEN; NITROREDUCTASE; NUCLEAR PROTEIN; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TRANSFORMATION; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CELL NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOTRANSFORMATION; CARBON MONOXIDE; CELL NUCLEUS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; LIPID PEROXIDATION; LIVER; MALE; NADP; NADPH-FERRIHEMOPROTEIN REDUCTASE; NIFURTIMOX; NITROREDUCTASES; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 0031462648     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bernacchi A.S., Castro C.R. de, Toranzo E.G.D. de and Castro, J.A. (1986). Effects of Nifurtimox or Benznidazole administration on rat testes: Ultrastructural observation and biochemical studies. Exptl. Mol. Pathol. 45: 245-256.
2. Castro C.R. de, Toranzo E.G.D. de, Bernacchi A.S., Carbone M and Castro J.A. (1989). Ultrastructural alterations in ovaries from nifurtimox or benznidazole-treated rats. Their relation to ovarian nitroreductive biotransformation of both drugs. Exptl. Mol. Pathol. 50: 385-397.
3. Castro G.D., A.J. López and Castro J.A. (1988). Evidence for hydroxyl free radical formation during Paraquat but not for Nifurtimox liver microsomal biotransformation. A dimethyl-sulfoxide scavening study. Arch. Toxicol. 62: 355-358.
4. 4 reactive metabolites and liver DNA and nuclear protein fractions. Carcinogenesis 10: 289-294.
5. Castro, J.A. and Toranzo, E.G.D. de (1988). Toxic effects of Nifurtimox and Benznidazole, two drugs used against American Trypanosomiasis (Chagas' disease). Biomed. Environ. Sci. 1: 19-33.
6. Docampo R. and Moreno S.N. (1985). Biochemical toxicology of antiparasitic compounds used in the chemotherapy and chemoprophylaxis of American Trypanosomiasis (Chagas' disease). Rev. Biochem. Toxicol. 7: 159-204.
7. Ferreira R.C., Schwarz U. and Ferreira L.C. (1988). Activation of anti-Trypanosoma cruzi drugs to genotoxic metabolites promoted by mammalian microsomal enzymes. Mutat. Res. 204: 577-583.
8. Gad S.C. and Weil S.C. (1982). Statistics for foxicologists. In Principles and Methods of Toxicology (A.W. Hayes, Ed.). Raven Press, New York, pp. 273-320.
9. Gorla N., Díaz Gómez M.I. and Castro J.A. (1986). Interaction of Benznidazole reactive metabolites with rat liver deoxyribonucleic acid and nuclear proteins. Arch. Int. Pharmacodyn. Ther. 280: 22-31.
10. Gorla N.B. and Castro J.A. (1985). Micronucleus formation in bone marrow of mice treated with Nifurtimox or Benznidazole. Toxicol. Lett. 25: 259-263.
11. Graph Pad Software (1992). Graph Pad Instat. Instant Biostatistics. San Diego, California. Graph Pad Software, pp. 1-127.
12. Laplume H., Barouse A. and Cabrera H. (1982). Efectos indeseables de Nifurtimox y Benznidazol. Medicina (Buenos Aires) 43: 291.
13. Masana M., Toranzo E.G.D. de and Castro J.A. (1984). Studies on Nifurtimox nitroreductase activity in liver and other rat tissues. Arch. Int. Pharmacodyn. Ther. 270: 4-10.
14. Meirovich C.I., Montrull H.L., Gallerano R. and Sosa R. (1985). Alopurinol en el tratamiento de la enfermedad de Chagas cronica. Arq. Bras. Cardiol. 45: 217-223.
15. Melo M.E. and Ferreira L.C. (1990). Screening the mutagenic activities of commonly used antiparasitic drugs by the Simultest, a simplified Salmonella/microsome plate incorporation assay. Rev. Inst. Med. Trop. Sao Paulo 32: 269-274.
16. Moreno S.N., Palmero D.J., Palmero K.E. de, Docampo R. and Stoppani A.D.M. (1980). Stimulation of lipid peroxidation and ultrastructural alterations induced by Nifurtimox in mammalian tissues. Medicina (Buenos Aires) 40: 553-559.
17. Nagel R. and Nepomnaschy I. (1983). Mutagenicity of 2-antichagasic drugs and their metabolic deactivation. Mut. Res. 117: 237-242.
18. Ohnishi T., Ohashi Y., Nozu K. and Inoki S. (1980). Mutagenicity of Nifurtimox in Escherichia coli. Mut. Res. 77: 241-244.
19. Teixeira A.R.L., Calixto M.A. and Teixeira M.L. (1994). Chagas' disease: carcinogenic activity of the antitrypanosomal nitroarenes in mice. Mut. Res. 305: 189-196.
20. Willis E.D. (1987). In Biochemical Toxicology. A Practical Approach (K.P. Snell and B. Mullak, Eds.), Chapter 6, IRL Press, Oxford, Washington DC, pp. 138-140.
21. World Health Organization (WHO) (1981). Workshop on guidelines for standarized protocols for the chemotherapy of Chagas' disease. TDR/ CHEMCHA/ DCWKSHP/ 8/ 3, pp 1-12.